A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...

This week, doctors announced that an Australian man with severe heart failure had left hospital with an artificial heart that ...

The US Food and Drug Administration (FDA) accepted and granted Priority Review designation for Bayer’s (BAYN: DE) supplemental new drug application (sNDA) for a new indication for Kerendia (finerenone ...

From his lab at the University of Houston College of Pharmacy Drug Discovery Institute, Mingfu Wu, associate professor, is ...

Several months ago, I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from about 50% of the daily value ...

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

The young patient is one of the world’s first to receive cardiac rehabilitation workouts while a device helps her heart pump.

Rowing machines and treadmills do not challenge your cardiovascular system in the same way, so what is the science behind it?

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

Several months ago, I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from about 50% of the daily value ...